Amarin Corp Plc (AMRN)

[Jasbg]

inv92@ As i said I'm a Lay person in Law - which is confirmed by your input.
---------------------
Looking for an answer (who sued who) I think you are right - in the sense that it was Amarin 'protecting the patens' made on the back of the R-I Trial - that started the case.

Meaning I only now understand this basic part of the whole matter - that the original Vascepa patent in USA were running out - which is why Hikma and Reddy were planning on a generic version of Vascepa (this how i understand it).

How and where i found these answers does put a somewhat more Insecure Light on the Appeal Case - I'm afraid.
-----------------------

Markman evaluation before judge Du ruling:

https://www.markmanadvisors.com/blog/2020/1/6/how-will-reduce-it-impact-generic-entry-for-amarins-vascepa


Markman after the marts 30. Ruling:

https://www.markmanadvisors.com/blog/2020/3/31/can-amarin-win-on-appeal-in-the-vascepa-patent-litigation

Jasbg